Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: Assessment by dipyridamole thallium-201 scintigraphy
- 1 November 1990
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 120 (5), 1073-1077
- https://doi.org/10.1016/0002-8703(90)90118-h
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitusThe American Journal of Cardiology, 1989
- Quantitative comparison of thallium-201 scintigraphy after exercise and dipyridamole in coronary artery diseaseThe American Journal of Cardiology, 1989
- Dipyridamole cardiac imagingAmerican Heart Journal, 1988
- Lipids, diabetes, and coronary heart disease: Insights from the Framingham StudyAmerican Heart Journal, 1985
- Determination of Cardiac Risk by Dipyridamole-Thallium Imaging before Peripheral Vascular SurgeryNew England Journal of Medicine, 1985
- Prognosis of patients with diabetes mellitus after acute myocardial infarctionThe American Journal of Cardiology, 1984
- Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitusAmerican Heart Journal, 1984
- Noninvasive detection and localization of coronary stenoses in patients: Comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imagingAmerican Heart Journal, 1982
- Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatationThe American Journal of Cardiology, 1978
- Clinical features of unrecognized myocardial infarction—Silent and symptomaticThe American Journal of Cardiology, 1973